169 related articles for article (PubMed ID: 36449173)
1. Estimating the Relationship Between EQ-5D-5L and EQ-5D-3L: Results from a UK Population Study.
Hernández Alava M; Pudney S; Wailoo A
Pharmacoeconomics; 2023 Feb; 41(2):199-207. PubMed ID: 36449173
[TBL] [Abstract][Full Text] [Related]
2. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
Feng Y; Devlin N; Herdman M
Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
[TBL] [Abstract][Full Text] [Related]
3. Population norms for the EQ-5D-3L and EQ-5D-5L in Romania.
Olariu E; Caplescu R; Vale L; Niculescu-Aron IG; Oluboyede Y; Paveliu MS
Health Qual Life Outcomes; 2023 Jul; 21(1):80. PubMed ID: 37507760
[TBL] [Abstract][Full Text] [Related]
4. EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom.
Hernandez Alava M; Wailoo A; Grimm S; Pudney S; Gomes M; Sadique Z; Meads D; O'Dwyer J; Barton G; Irvine L
Value Health; 2018 Jan; 21(1):49-56. PubMed ID: 29304940
[TBL] [Abstract][Full Text] [Related]
5. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
6. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
7. Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care.
Verstraete J; Marthinus Z; Dix-Peek S; Scott D
Health Qual Life Outcomes; 2022 Feb; 20(1):28. PubMed ID: 35177084
[TBL] [Abstract][Full Text] [Related]
8. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
Pattanaphesaj J; Thavorncharoensap M
Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
[TBL] [Abstract][Full Text] [Related]
9. Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China.
Weng G; Hong Y; Luo N; Mukuria C; Jiang J; Yang Z; Li S
Eur J Health Econ; 2023 Mar; 24(2):197-207. PubMed ID: 35538178
[TBL] [Abstract][Full Text] [Related]
10. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.
Feng Y; Herdman M; van Nooten F; Cleeland C; Parkin D; Ikeda S; Igarashi A; Devlin NJ
Qual Life Res; 2017 Aug; 26(8):2067-2078. PubMed ID: 28343350
[TBL] [Abstract][Full Text] [Related]
11. Head-to-Head Comparison of EQ-5D-3L and EQ-5D-5L Health Values.
Selivanova A; Buskens E; Krabbe PFM
Pharmacoeconomics; 2018 Jun; 36(6):715-725. PubMed ID: 29623559
[TBL] [Abstract][Full Text] [Related]
12. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
[TBL] [Abstract][Full Text] [Related]
13. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
Jankowska A; Młyńczak K; Golicki D
Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
[TBL] [Abstract][Full Text] [Related]
14. A head-to-head comparison of the measurement properties of EQ-5D-3L and EQ-5D-5L in Chinese family caregivers of cancer patients.
Zhang H; Liu B; Gu W; Cao Y; Xu J; Tan RL; Chang E; Zheng W; Li H; Zhou L; Jia Y; Yang H; Guo S; Huang W; Luo N
Support Care Cancer; 2023 Dec; 32(1):14. PubMed ID: 38060009
[TBL] [Abstract][Full Text] [Related]
15. Danish population health measured by the EQ-5D-5L.
Jensen MB; Jensen CE; Gudex C; Pedersen KM; Sørensen SS; Ehlers LH
Scand J Public Health; 2023 Mar; 51(2):241-249. PubMed ID: 34847818
[TBL] [Abstract][Full Text] [Related]
16. Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.
Zhu J; Yan XX; Liu CC; Wang H; Wang L; Cao SM; Liao XZ; Xi YF; Ji Y; Lei L; Xiao HF; Guan HJ; Wei WQ; Dai M; Chen W; Shi JF
Qual Life Res; 2021 Mar; 30(3):841-854. PubMed ID: 32930993
[TBL] [Abstract][Full Text] [Related]
17. Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.
Jiang J; Hong Y; Zhang T; Yang Z; Lin T; Liang Z; Lu P; Liu L; Wang B; Xu Y; Luo N
Qual Life Res; 2021 Jul; 30(7):2045-2060. PubMed ID: 33821418
[TBL] [Abstract][Full Text] [Related]
18. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.
Pickard AS; De Leon MC; Kohlmann T; Cella D; Rosenbloom S
Med Care; 2007 Mar; 45(3):259-63. PubMed ID: 17304084
[TBL] [Abstract][Full Text] [Related]
19. Health problems are more common, but less severe when measured using newer EQ-5D versions.
Craig BM; Pickard AS; Lubetkin EI
J Clin Epidemiol; 2014 Jan; 67(1):93-9. PubMed ID: 24075597
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in patients with lower limb amputation - an assessment of the measurement properties of EQ-5D-3L and EQ-5D-5L using data from the Swedish Amputation and Prosthetics Registry.
Ernstsson O; Hagberg K; Janssen MF; Bonsel GJ; Korkmaz S; Zethraeus N; Heintz E
Disabil Rehabil; 2022 Dec; 44(26):8471-8479. PubMed ID: 34932426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
